Immunopeptidomics informs discovery and delivery of Mycobacterium tuberculosis MHC-II antigens for vaccine design
Leddy, O.; Ogongo, P.; Huffaker, J.; Gan, M.; Milligan, R.; Mahmud, S.; Yuki, Y.; Bobosha, K.; Wassie, L.; Carrington, M.; Liu, Q.; Ernst, J. D.; White, F. M.; Bryson, B. D.
10.1101/2024.10.02.616386 bioRxivShow abstract
No currently licensed vaccine reliably prevents pulmonary tuberculosis (TB), a leading cause of infectious disease mortality. Developing effective new vaccines will require identifying which of the roughly 4000 proteins in the Mycobacterium tuberculosis (Mtb) proteome are presented on MHC class II (MHC-II) by infected human phagocytes and can be recognized by CD4+ T cells to mediate protective immunity. Vaccines must also elicit T cell responses recognizing the same peptide-MHC complexes presented by infected cells, and successful presentation of target human MHC-II peptides is currently challenging to evaluate and optimize. Here, we define antigenic targets for TB vaccine development by using mass spectrometry (MS) for proteome-wide discovery of Mtb epitopes presented on MHC-II by infected human cells. We next iteratively design and evaluate candidate mRNA vaccine immunogens, revealing design principles that enhance presentation of target MHC-II peptides. Our results will inform the development of new TB vaccine candidates.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Multiplexed relative and absolute quantitative immunopeptidomics reveals MHC I repertoire alterations induced by CDK4/6 inhibition 96%
- Metformin enhances anti-mycobacterial responses by educating immunometabolic circuits of CD8+ T cells 94%
- A stabilized MERS-CoV spike ferritin nanoparticle vaccine elicits robust and protective neutralizing antibody responses 94%
Similar papers in this journal
- MEK inhibition enhances presentation of targetable MHC-I tumor antigens in mutant melanomas 95%
- Trehalose dimycolate inhibits phagosome maturation and promotes intracellular M. tuberculosis growth via noncanonical SNARE interaction 94%
- Turncoat antibodies unmasked in a model of autoimmune demyelination: from biology to therapy 94%
Similar papers in this journal
- Cysteine reactivity profiling identifies host regulators of Mycobacterium tuberculosis replication in human macrophages 97%
- Structural basis for postfusion-specific binding to Respiratory Syncytial Virus F protein by the canonical antigenic site I antibody 131-2a 93%
- Immunogenicity and protective efficacy of a highly thermotolerant, trimeric SARS-CoV-2 receptor binding domain derivative 93%
Similar papers in this journal
- Immunopeptidomics reveals determinants of Mycobacterium tuberculosis antigen presentation on MHC class I 98%
- Comprehensive characterization of the antibody responses to SARS-CoV-2 Spike protein after infection and/or vaccination 94%
- Modular DNA Barcoding of Nanobodies Enables Multiplexed in situ Protein Imaging and High-throughput Biomolecule Detection 94%
Similar papers in this journal
- CD4+CCR6+ T cells dominate the BCG-induced transcriptional signature 95%
- Citrullination of a phage displayed human peptidome library reveals the fine specificities of rheumatoid arthritis-associated autoantibodies 94%
- The BNT162b2 mRNA SARS-CoV-2 vaccine induces transient afucosylatedIgG1 in naive but not antigen-experienced vaccinees 92%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.